Theravance Biopharma Inc (TBPH) AI-Powered Stock Analysis
See how Theravance Biopharma Inc scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
TBPH●NASDAQ
HealthcareMedical - Pharmaceuticals
$16.84
$0.09(0.53%)
U.S. Market is Open · 15:55
Theravance Biopharma Inc (TBPH)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerTheravance Biopharma Inc (TBPH) Stock Overall Grade
Theravance Biopharma Inc’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Theravance Biopharma Inc's overall stock rating.
Forecast
B+Score
77/100Financial Growth
CScore
40/100Fundamental Growth
B+Score
78/100Key Ratios
A+Score
100/100Sector Comparison
AScore
85/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Theravance Biopharma Inc (TBPH) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 77/100 (B+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (78/100, B+) highlight its stability, while Key Ratios (100/100, A+) and Sector Comparison (85/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Theravance Biopharma Inc stock grade, including financials, comparisons, and forecasts.